Suibiovac ART Inaktywowane bakterie Bordetella bronchiseptica (BB 4-78) nie mniej niż 8 x 10^9, Inaktywowane bakterie Pasteurella multocida typ D (CECT 4325) nie mniej niż 8 x 10^9, Letalna dermonekrotoksyna Pasteurella multocida (DNT) nie mniej niż 1 µg, Zawiesina do wstrzykiwań
Suibiovac ART Inaktywowane bakterie Bordetella bronchiseptica (BB 4-78) nie mniej niż 8 x 10^9, Inaktywowane bakterie Pasteurella multocida typ D (CECT 4325) nie mniej niż 8 x 10^9, Letalna dermonekrotoksyna Pasteurella multocida (DNT) nie mniej niż 1 µg, Zawiesina do wstrzykiwań
Authorised
- Bordetella bronchiseptica, strain BB4-78, Inactivated
- Pasteurella multocida, serotype D, strain CECT 4325, Inactivated
- Pasteurella multocida, non-toxic derivative of dermonecrotic toxin, recombinant
Product identification
Medicine name:
Suibiovac ART Inaktywowane bakterie Bordetella bronchiseptica (BB 4-78) nie mniej niż 8 x 10^9, Inaktywowane bakterie Pasteurella multocida typ D (CECT 4325) nie mniej niż 8 x 10^9, Letalna dermonekrotoksyna Pasteurella multocida (DNT) nie mniej niż 1 µg, Zawiesina do wstrzykiwań
Active substance:
- Bordetella bronchiseptica, strain BB4-78, Inactivated
- Pasteurella multocida, serotype D, strain CECT 4325, Inactivated
- Pasteurella multocida, non-toxic derivative of dermonecrotic toxin, recombinant
Target species:
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain BB4-78, Inactivated8000.00/million unit(s)/millilitre2.00millilitre(s)
-
Pasteurella multocida, serotype D, strain CECT 4325, Inactivated8000.00/million unit(s)/millilitre2.00millilitre(s)
-
Pasteurella multocida, non-toxic derivative of dermonecrotic toxin, recombinant1.00/microgram(s)2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.U.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2540
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
